US2844579A
(en)
|
|
1958-07-22 |
|
Process for thiamine monomtrate |
US3180859A
(en)
|
1962-12-05 |
1965-04-27 |
Upjohn Co |
Derivatives of decoyinine and process for preparing same
|
US3431252A
(en)
|
1966-04-01 |
1969-03-04 |
Merck & Co Inc |
5,5-dialkyl-d-ribofuranosyl purine compounds and intermediates
|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
US3816399A
(en)
|
1970-07-14 |
1974-06-11 |
Univ Bradford |
1-amine nucleosides
|
GB1319303A
(en)
|
1970-07-14 |
1973-06-06 |
Univ Bradford |
Sugar derivatives
|
US3872098A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
1,n{hu 6{b ethenoadenosine cyclophosphate compounds
|
US3872084A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
Purine nucleoside 3,5-cyclicphosphate compounds
|
US4093714A
(en)
|
1974-03-15 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
9β-D-Arabinofuranosylpurine nucleotides and method of use
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
PL144471B1
(en)
|
1985-04-22 |
1988-05-31 |
Polska Akad Nauk Centrum |
Method of obtaining novel 3',5'-cyclic adensine dithiophosphate
|
DK224286A
(da)
|
1985-05-15 |
1986-11-16 |
Wellcome Found |
2',3'-dideoxy-nucleosider
|
JPH0446124Y2
(es)
|
1986-02-25 |
1992-10-29 |
|
|
AU8276187A
(en)
|
1986-10-31 |
1988-05-25 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
IL86007A0
(en)
|
1987-04-09 |
1988-09-30 |
Wellcome Found |
6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
|
US4885739A
(en)
|
1987-11-13 |
1989-12-05 |
Dsc Communications Corporation |
Interprocessor switching network
|
DE3824110A1
(de)
|
1988-07-15 |
1990-01-18 |
Max Planck Gesellschaft |
Verfahren zur herstellung und reinigung von an ihrem 5'-ende phosphorylierten oligo- und jpolynukleotidsequenzen und reagenz zur durchfuehrung des verfahrens
|
DK582489A
(da)
|
1988-11-21 |
1990-05-22 |
Syntex Inc |
Substituerede 2'-deoxy-4'-azido-nucleosider, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende samme
|
DD279247A1
(de)
|
1989-01-01 |
1990-05-30 |
Akad Wissenschaften Ddr |
Verfahren zur herstellung von 1-beta-d-allofuranosylthyminnucleosiden
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
GB9009861D0
(en)
|
1990-05-02 |
1990-06-27 |
Glaxo Group Ltd |
Chemical compounds
|
JPH0446124A
(ja)
|
1990-06-13 |
1992-02-17 |
Advance Co Ltd |
抗潰瘍剤
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
US6087482A
(en)
|
1990-07-27 |
2000-07-11 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
AU665184B2
(en)
|
1991-01-23 |
1995-12-21 |
Gensia, Inc. |
Adenosine kinase inhibitors
|
EP0586523A4
(en)
|
1991-05-15 |
1995-11-29 |
Univ Yale |
Determination of prodrugs metabolizable by the liver and therapeutic use thereof
|
IT1249732B
(it)
|
1991-11-26 |
1995-03-09 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso.
|
US6469158B1
(en)
|
1992-05-14 |
2002-10-22 |
Ribozyme Pharmaceuticals, Incorporated |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5804683A
(en)
|
1992-05-14 |
1998-09-08 |
Ribozyme Pharmaceuticals, Inc. |
Deprotection of RNA with alkylamine
|
US5686599A
(en)
|
1992-05-14 |
1997-11-11 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5714383A
(en)
|
1992-05-14 |
1998-02-03 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for treating chronic myelogenous leukemia
|
US5977343A
(en)
|
1992-05-14 |
1999-11-02 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5625056A
(en)
|
1992-05-26 |
1997-04-29 |
Biolog Life Science Institute |
Derivatives of cyclic guanosine-3',5'-monophosphorothioate
|
US5721350A
(en)
|
1992-06-18 |
1998-02-24 |
Chattopadhyaya; Jyoti |
Deuterated nucleosides
|
US5811300A
(en)
|
1992-12-07 |
1998-09-22 |
Ribozyme Pharmaceuticals, Inc. |
TNF-α ribozymes
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
US5837542A
(en)
|
1992-12-07 |
1998-11-17 |
Ribozyme Pharmaceuticals, Inc. |
Intercellular adhesion molecule-1 (ICAM-1) ribozymes
|
US5616488A
(en)
|
1992-12-07 |
1997-04-01 |
Ribozyme Pharmaceuticals, Inc. |
IL-5 targeted ribozymes
|
JPH06228186A
(ja)
|
1993-01-29 |
1994-08-16 |
Yamasa Shoyu Co Ltd |
2’−デオキシ−(2’s)−アルキルピリミジンヌクレオシド誘導体
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
AU6551094A
(en)
|
1993-03-31 |
1994-10-24 |
Sterling Winthrop Inc. |
Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
|
WO1994022890A1
(en)
|
1993-03-31 |
1994-10-13 |
Sterling Winthop Inc. |
Novel 5'-substituted nucleosides and oligomers produced therefrom
|
GB9311682D0
(en)
|
1993-06-05 |
1993-07-21 |
Ciba Geigy Ag |
Chemical compounds
|
US5552311A
(en)
|
1993-09-14 |
1996-09-03 |
University Of Alabama At Birmingham Research Foundation |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US6017896A
(en)
|
1993-09-14 |
2000-01-25 |
University Of Alabama Research Foundation And Southern Research Institute |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US6491905B1
(en)
|
1993-09-14 |
2002-12-10 |
The Uab Research Foundation |
Recombinant bacterial cells for delivery of PNP to tumor cells
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
ES2127948T3
(es)
|
1993-10-27 |
1999-05-01 |
Ribozyme Pharm Inc |
Oligonucleotidos modificados en la posicion 2'-amido y 2'-peptido.
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
WO1995018139A1
(en)
|
1993-12-30 |
1995-07-06 |
Chemgenes Corporation |
Synthesis of propargyl modified nucleosides and phosphoramidites and their incorporation into defined sequence oligonucleotides
|
US5639647A
(en)
|
1994-03-29 |
1997-06-17 |
Ribozyme Pharmaceuticals, Inc. |
2'-deoxy-2'alkylnucleotide containing nucleic acid
|
US5631359A
(en)
|
1994-10-11 |
1997-05-20 |
Ribozyme Pharmaceuticals, Inc. |
Hairpin ribozymes
|
US5902880A
(en)
|
1994-08-19 |
1999-05-11 |
Ribozyme Pharmaceuticals, Inc. |
RNA polymerase III-based expression of therapeutic RNAs
|
US5693532A
(en)
|
1994-11-04 |
1997-12-02 |
Ribozyme Pharmaceuticals, Inc. |
Respiratory syncytial virus ribozymes
|
US5620676A
(en)
|
1994-03-08 |
1997-04-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biologically active ATP analogs
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
US5871918A
(en)
|
1996-06-20 |
1999-02-16 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US5580967A
(en)
|
1994-05-13 |
1996-12-03 |
The Scripps Research Institute |
Optimized catalytic DNA-cleaving ribozymes
|
US6063566A
(en)
|
1994-05-13 |
2000-05-16 |
The Scripps Research Institute |
Catalytic RNA molecules
|
GB9417746D0
(en)
|
1994-09-03 |
1994-10-19 |
Ciba Geigy Ag |
Chemical compounds
|
GB9417938D0
(en)
|
1994-09-06 |
1994-10-26 |
Ciba Geigy Ag |
Compounds
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
US7141665B1
(en)
|
1998-04-29 |
2006-11-28 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
KR100330602B1
(ko)
|
1995-02-01 |
2002-08-22 |
레스프로텍트 게엠베하 |
세포증식억제처치에있어서내성형성에대한5'-치환뉴클레오시드의이용및이들뉴클레오시드류를함유하는약제
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
AU4931196A
(en)
|
1995-03-24 |
1996-10-16 |
Christian Noe |
Nucleic acid polyester polyamides
|
US5968745A
(en)
|
1995-06-27 |
1999-10-19 |
The University Of North Carolina At Chapel Hill |
Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
|
US6132971A
(en)
|
1995-06-27 |
2000-10-17 |
The University Of North Carolina At Chapel Hill |
Microelectronic device
|
US6361951B1
(en)
|
1995-06-27 |
2002-03-26 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US6004939A
(en)
|
1995-07-06 |
1999-12-21 |
Ctrc Research Foundation Board Of Regents |
Methods for modulation and inhibition of telomerase
|
US20010011075A1
(en)
|
1999-02-05 |
2001-08-02 |
Leroy B Townsend |
5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
|
ATE373672T1
(de)
|
1996-01-16 |
2007-10-15 |
Sirna Therapeutics Inc |
Synthese von methoxynukleoside und enzymatische nukleisäure moleküle
|
US5767097A
(en)
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
EP0799834A1
(en)
|
1996-04-04 |
1997-10-08 |
Novartis AG |
Modified nucleotides
|
US20040171028A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050032067A1
(en)
|
2002-11-05 |
2005-02-10 |
Prakash Thazha P. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20040171032A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050042647A1
(en)
|
1996-06-06 |
2005-02-24 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
WO1998000434A1
(en)
|
1996-06-28 |
1998-01-08 |
Novartis Ag |
Modified oligonucleotides
|
NZ505531A
(en)
|
1996-10-16 |
2001-08-31 |
Icn Pharmaceuticals |
7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside
|
PT1027359E
(pt)
|
1996-10-16 |
2003-09-30 |
Ribapharm Inc |
L-nucleosideos monociclicos analogos e suas utilizacoes
|
CA2269213A1
(en)
|
1996-10-28 |
1998-05-07 |
The University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
|
US6887707B2
(en)
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
US7078391B2
(en)
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
WO2002095010A2
(en)
|
2001-03-21 |
2002-11-28 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
US20030144489A1
(en)
|
1997-06-09 |
2003-07-31 |
Alex Burgin |
Method for screening nucleic acid catalysts
|
AU9210498A
(en)
|
1997-08-29 |
1999-03-16 |
Gilead Sciences, Inc. |
5',5'-linked oligomers having anti-thrombin activity
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US6232463B1
(en)
|
1997-10-09 |
2001-05-15 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US6528640B1
(en)
|
1997-11-05 |
2003-03-04 |
Ribozyme Pharmaceuticals, Incorporated |
Synthetic ribonucleic acids with RNAse activity
|
US6617438B1
(en)
|
1997-11-05 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Oligoribonucleotides with enzymatic activity
|
US20030004122A1
(en)
|
1997-11-05 |
2003-01-02 |
Leonid Beigelman |
Nucleotide triphosphates and their incorporation into oligonucleotides
|
US6482932B1
(en)
|
1997-11-05 |
2002-11-19 |
Ribozyme Pharmaceuticals, Incorporated |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
US6015703A
(en)
|
1998-03-10 |
2000-01-18 |
Iogen Corporation |
Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
|
CA2330574A1
(en)
|
1998-04-29 |
1999-11-04 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
US6030957A
(en)
|
1998-06-29 |
2000-02-29 |
Wayne Hughes Institute |
Aryl phosphate derivatives of d4T having anti-HIV activity
|
US7091315B1
(en)
|
1998-07-15 |
2006-08-15 |
Human Genome Sciences, Inc. |
Protein HDPBQ71
|
WO2000014263A2
(en)
|
1998-09-03 |
2000-03-16 |
Board Of Regents, The University Of Texas System |
Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
US7064114B2
(en)
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
JP2002540080A
(ja)
|
1999-03-19 |
2002-11-26 |
パーカー ヒューズ インスティテュート |
ゲルミクロ乳濁液製剤
|
US20040023265A1
(en)
|
1999-07-02 |
2004-02-05 |
Jeevalatha Vivekananda |
Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin
|
US6569630B1
(en)
|
1999-07-02 |
2003-05-27 |
Conceptual Mindworks, Inc. |
Methods and compositions for aptamers against anthrax
|
WO2001009317A1
(fr)
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Gene associe au cancer de l'estomac
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
WO2001027114A1
(en)
|
1999-08-27 |
2001-04-19 |
Icn Pharmaceuticals, Inc. |
PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
|
US6649750B1
(en)
|
2000-01-05 |
2003-11-18 |
Isis Pharmaceuticals, Inc. |
Process for the preparation of oligonucleotide compounds
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
WO2001060315A2
(en)
|
2000-02-18 |
2001-08-23 |
Shire Biochem Inc. |
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
|
US7235649B2
(en)
|
2000-03-24 |
2007-06-26 |
Duke University |
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
|
JP2003528886A
(ja)
|
2000-03-24 |
2003-09-30 |
デューク・ユニバーシティ |
Crp94−リガンド相互作用の特徴付けおよびそれに関連する精製、スクリーニングおよび治療法
|
FR2808797A1
(fr)
|
2000-05-09 |
2001-11-16 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments
|
WO2001090304A2
(en)
|
2000-05-19 |
2001-11-29 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
US20020132237A1
(en)
|
2000-05-26 |
2002-09-19 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
YU92202A
(sh)
|
2000-05-26 |
2006-01-16 |
Idenix (Cayman) Limited |
Metode i smeše za lečenje flavi virusa i pesti virusa
|
ES2227203T3
(es)
|
2000-05-26 |
2005-04-01 |
Idenix (Cayman) Limited |
Metodos para tratar la infeccion por el virus de la hepatitis delta con beta-1-2'-desoxinucleosidos.
|
US6974667B2
(en)
|
2000-06-14 |
2005-12-13 |
Gene Logic, Inc. |
Gene expression profiles in liver cancer
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
PT2281843T
(pt)
|
2000-06-16 |
2017-01-02 |
Human Genome Sciences Inc |
Anticorpos que se ligam imunoespecificamente a blys
|
US20030207271A1
(en)
|
2000-06-30 |
2003-11-06 |
Holwitt Eric A. |
Methods and compositions for biological sensors
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US20030166064A1
(en)
|
2000-08-03 |
2003-09-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
WO2002022660A2
(en)
|
2000-09-11 |
2002-03-21 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
WO2002026930A2
(en)
|
2000-09-26 |
2002-04-04 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
CN1133642C
(zh)
|
2000-10-09 |
2004-01-07 |
清华大学 |
核苷5’-硫代磷酰氨基酸酯化合物
|
EP2141244A1
(en)
|
2000-10-18 |
2010-01-06 |
Pharmasset, Inc. |
Multiplex quantification of nucleic acids in diseased cells
|
US20020150922A1
(en)
|
2000-11-20 |
2002-10-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
CZ20032005A3
(en)
|
2001-01-22 |
2004-04-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
AU2002251841A1
(en)
|
2001-01-30 |
2002-08-12 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
WO2002097031A2
(en)
|
2001-03-28 |
2002-12-05 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US6995148B2
(en)
|
2001-04-05 |
2006-02-07 |
University Of Pittsburgh |
Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
|
CN1186456C
(zh)
|
2001-04-30 |
2005-01-26 |
曹卫 |
通用模板核酸检测方法和试剂盒
|
US6881831B2
(en)
|
2001-05-16 |
2005-04-19 |
Migenix Inc. |
Nucleic acid-based compounds and methods of use thereof
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
AU2002344237B8
(en)
|
2001-05-29 |
2008-11-06 |
Sirna Therapeutics, Inc. |
Nucleic Acid Based Modulation of Female Reproductive Diseases and Conditions
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
CA2457819A1
(en)
|
2001-08-14 |
2003-02-27 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
WO2003016572A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Oligonucleotide therapeutics for treating hepatitis c virus infections
|
WO2003016497A2
(en)
|
2001-08-17 |
2003-02-27 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
CN1133641C
(zh)
*
|
2001-08-24 |
2004-01-07 |
清华大学 |
一种含有3'叠氮胸苷的硫代磷酰氨基酸酯化合物及其制备方法
|
CN1159332C
(zh)
|
2001-08-24 |
2004-07-28 |
清华大学 |
一种硫代磷酰氨基酸酯化合物及其制备方法
|
CN1186457C
(zh)
|
2001-08-29 |
2005-01-26 |
曹卫 |
均相基因矩阵
|
AU2002343417A1
(en)
|
2001-09-24 |
2003-04-14 |
Nuvelo |
Novel nucleic acids and polypeptides
|
JP2005525788A
(ja)
|
2001-09-28 |
2005-09-02 |
インサイト・ゲノミックス・インコーポレイテッド |
酵素
|
EP1442027A1
(en)
|
2001-10-09 |
2004-08-04 |
3-Dimensional Pharmaceuticals, Inc. |
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
|
US20050186568A1
(en)
|
2001-10-19 |
2005-08-25 |
Olga Bandman |
Kinases and phosphatases
|
US7488598B2
(en)
|
2001-10-26 |
2009-02-10 |
Cornell Center For Technology Enterprise And Commercialization |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
US7037718B2
(en)
|
2001-10-26 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
EP1497315A2
(en)
|
2001-10-29 |
2005-01-19 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
EP1504101A2
(en)
|
2001-11-09 |
2005-02-09 |
Incyte Genomics, Inc. |
Intracellular signaling molecules
|
AU2002366951A1
(en)
|
2001-12-10 |
2003-07-09 |
Nuvelo,Inc. |
Novel nucleic acids and polypeptides
|
AU2002340387A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
WO2003054219A2
(en)
|
2001-12-19 |
2003-07-03 |
Incyte Corporation |
Nucleic acid-associated proteins
|
CA2471307A1
(en)
|
2001-12-20 |
2003-09-04 |
Cellzome Ag |
Protein complexes and methods for their use
|
WO2003062376A2
(en)
|
2002-01-16 |
2003-07-31 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
WO2003062379A2
(en)
|
2002-01-17 |
2003-07-31 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
US20070032448A1
(en)
|
2002-01-17 |
2007-02-08 |
Zhi Hong |
Sugar modified nucleosides as viral replication inhibitors
|
AU2003207628A1
(en)
|
2002-01-18 |
2003-09-02 |
Incyte Corporation |
Structural and cytoskeleton-associated proteins
|
AU2003205353A1
(en)
|
2002-01-25 |
2003-09-02 |
Incyte Genomics, Inc. |
Protein modification and maintenance molecules
|
US20050042632A1
(en)
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US20080207542A1
(en)
|
2002-03-26 |
2008-08-28 |
Sirna Therapeutics, Inc. |
RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
|
WO2003072729A2
(en)
|
2002-02-22 |
2003-09-04 |
Incyte Corporation |
Enzymes
|
EP1485395A4
(en)
|
2002-02-28 |
2011-04-13 |
Biota Scient Management |
NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
|
ATE408711T1
(de)
|
2002-03-01 |
2008-10-15 |
Integrated Dna Tech Inc |
Polynomiale amplifikation von nukleinsäuren
|
WO2003076586A2
(en)
|
2002-03-06 |
2003-09-18 |
Incyte Corporation |
Nucleic acid-associated proteins
|
AU2003218238A1
(en)
|
2002-03-15 |
2003-09-29 |
Incyte Corporation |
Proteins associated with growth, differentiation, and death
|
WO2003083085A2
(en)
|
2002-03-28 |
2003-10-09 |
Incyte Corporation |
Transporters and ion channels
|
AU2003220607A1
(en)
|
2002-03-29 |
2003-10-13 |
Incyte Corporation |
Enzymes
|
AU2003231981A1
(en)
|
2002-03-29 |
2003-10-13 |
Incyte Corporation |
Protein modification and maintenance molecules
|
WO2003087300A2
(en)
|
2002-04-05 |
2003-10-23 |
Incyte Corporation |
Secreted proteins
|
US20030190626A1
(en)
|
2002-04-09 |
2003-10-09 |
Vasulinga Ravikumar |
Phosphorothioate monoester modified oligomers
|
US20060074035A1
(en)
|
2002-04-17 |
2006-04-06 |
Zhi Hong |
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
|
US20050288258A1
(en)
|
2002-04-23 |
2005-12-29 |
Diana Guy D |
Compounds, compositions and methods for treating or preventing viral infections and associated diseases
|
WO2003093439A2
(en)
|
2002-04-29 |
2003-11-13 |
Incyte Corporation |
Enzymes
|
CN1653077A
(zh)
|
2002-05-06 |
2005-08-10 |
健亚生物科技公司 |
治疗c型肝炎病毒感染的核苷衍生物
|
AU2003232086A1
(en)
|
2002-05-10 |
2003-11-11 |
Incyte Corporation |
Nucleic acid-associated proteins
|
JP2004046124A
(ja)
|
2002-05-15 |
2004-02-12 |
Semiconductor Energy Lab Co Ltd |
パッシブマトリクス型発光装置
|
FR2840318B1
(fr)
|
2002-05-29 |
2004-12-03 |
Quoc Kiet Pham |
Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
|
JP4902958B2
(ja)
|
2002-06-07 |
2012-03-21 |
ユニバーシテール・メディッシュ・セントラム・ユトレヒト |
cAMPによって直接活性化される交換タンパク質(Epac)の活性をモジュレートするための新規な化合物
|
AU2003245627A1
(en)
|
2002-06-21 |
2004-01-06 |
Incyte Corporation |
Kinases and phosphatases
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
WO2004003000A2
(en)
|
2002-06-28 |
2004-01-08 |
Idenix (Cayman) Limited |
1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
|
AU2003245747A1
(en)
|
2002-06-28 |
2004-01-19 |
Incyte Corporation |
Enzymes
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
AU2003268023A1
(en)
|
2002-07-23 |
2004-02-09 |
Incyte Corporation |
Protein modification and maintenance molecules
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
GB0221694D0
(en)
|
2002-09-18 |
2002-10-30 |
Glaxo Group Ltd |
Compounds
|
AU2003278904A1
(en)
|
2002-09-24 |
2004-04-19 |
Kornis Pharmaceuticals, Incorporated |
1, 3, 5-triazines for treatment of viral diseases
|
US20070207973A1
(en)
|
2002-09-24 |
2007-09-06 |
Koronis Pharmaceuticals, Incorporated |
1,3,5-Triazines for Treatment of Viral Diseases
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
WO2004050899A2
(en)
|
2002-12-03 |
2004-06-17 |
Archemix Corporation |
Method for in vitro selection of 2’-substituted nucleic acids
|
US20050037394A1
(en)
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
AU2003300901A1
(en)
|
2002-12-12 |
2004-06-30 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
JP4389443B2
(ja)
|
2002-12-20 |
2009-12-24 |
セイコーエプソン株式会社 |
インクジェットヘッドのワイピングユニット、これを備えた液滴吐出装置および電気光学装置の製造方法
|
SG173219A1
(en)
|
2002-12-23 |
2011-08-29 |
Dynavax Tech Corp |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
DK1628685T3
(da)
|
2003-04-25 |
2011-03-21 |
Gilead Sciences Inc |
Antivirale phosphonatanaloge
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US20090247488A1
(en)
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
UA82695C2
(uk)
|
2003-06-06 |
2008-05-12 |
Нисан Кемикал Индастриз, Лтд. |
Гетероароматичні сполуки як активатори рецептора тромбопоетину
|
US20070203083A1
(en)
|
2003-06-13 |
2007-08-30 |
Mootha Vamsi K |
Methods Of Regulating Metabolism And Mitochondrial Function
|
WO2005005658A1
(en)
|
2003-07-14 |
2005-01-20 |
Capitalbio Corporation |
Methods and compositions for detecting sars virus and other infectious agents
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
RU2006109491A
(ru)
|
2003-08-27 |
2006-08-10 |
Байота, Инк. (Au) |
Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств
|
US7151089B2
(en)
|
2003-10-27 |
2006-12-19 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
JP2007509180A
(ja)
|
2003-10-21 |
2007-04-12 |
インスパイアー ファーマシューティカルズ,インコーポレイティド |
疼痛を治療するための、非ヌクレオチド組成物および方法
|
US7504497B2
(en)
|
2003-10-21 |
2009-03-17 |
Inspire Pharmaceuticals, Inc. |
Orally bioavailable compounds and methods for inhibiting platelet aggregation
|
US7368438B2
(en)
|
2003-10-21 |
2008-05-06 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide compositions and method for inhibiting platelet aggregation
|
US7335648B2
(en)
|
2003-10-21 |
2008-02-26 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide composition and method for inhibiting platelet aggregation
|
US7749981B2
(en)
|
2003-10-21 |
2010-07-06 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
JP2005162732A
(ja)
|
2003-11-13 |
2005-06-23 |
Bayer Cropscience Ag |
殺虫性ニコチノイルカーバメート類
|
US20070238099A1
(en)
|
2003-12-08 |
2007-10-11 |
Cohen Irun R |
Antigen Receptor Variable Region Typing
|
US20070276139A1
(en)
|
2004-02-10 |
2007-11-29 |
Quanlai Song |
Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis
|
JP2007526253A
(ja)
|
2004-02-19 |
2007-09-13 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激性ウイルスrnaオリゴヌクレオチド
|
US8759317B2
(en)
|
2004-03-18 |
2014-06-24 |
University Of South Florida |
Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)
|
EP1765847A4
(en)
|
2004-05-27 |
2010-10-20 |
Alnylam Pharmaceuticals Inc |
NUCLEASERESISTENT DOUBLE-STRANDED RIBONUCLEIC ACID
|
GB0413726D0
(en)
|
2004-06-18 |
2004-07-21 |
Lauras As |
Compounds
|
JP2008504840A
(ja)
|
2004-06-30 |
2008-02-21 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
非リン酸骨格結合を含むオリゴヌクレオチド
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
ES2327252T3
(es)
|
2004-08-23 |
2009-10-27 |
F. Hoffmann-La Roche Ag |
4'-azido nucleosidos antivirales.
|
WO2006028742A2
(en)
|
2004-09-01 |
2006-03-16 |
Dynavax Technologies Corporation |
Methods and conpositions for inhibition of innate immune responses and autoimmunity
|
ES2769377T3
(es)
|
2004-09-14 |
2020-06-25 |
Gilead Pharmasset Llc |
Intermedios de D-ribonolactona con sustitución de 2-fluoro-2-alquilo
|
US7553653B2
(en)
|
2004-09-17 |
2009-06-30 |
Biomarin Pharmaceutical Inc. |
Variants and chemically-modified variants of phenylalanine ammonia-lyase
|
EP2982754A1
(en)
|
2004-09-24 |
2016-02-10 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of apob and uses thereof
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
CA2588979C
(en)
|
2004-12-08 |
2013-01-22 |
Nissan Chemical Industries, Ltd. |
3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
|
CA2589406A1
(en)
|
2004-12-09 |
2006-06-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
|
ES2525567T3
(es)
|
2004-12-17 |
2014-12-26 |
Anadys Pharmaceuticals, Inc. |
Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos
|
AU2005316503A1
(en)
|
2004-12-17 |
2006-06-22 |
Dynavax Technologies Corporation |
Methods and compositions for induction or promotion of immune tolerance
|
RU2007131689A
(ru)
|
2005-01-21 |
2009-02-27 |
Интроджен Тетрапьютикс, Инк. (Us) |
Местное введение терапевтических и профилактических нуклеиновых кислот, обеспечивающее их пролонгированное действие на клетки-мишени
|
JP2006228186A
(ja)
|
2005-01-24 |
2006-08-31 |
Yukichi Fukuyama |
携帯電話を用いた防犯方法および装置
|
US7638488B2
(en)
|
2005-03-08 |
2009-12-29 |
Intermune, Inc. |
Use of alpha-glucosidase inhibitors to treat alphavirus infections
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
JP2006248949A
(ja)
|
2005-03-09 |
2006-09-21 |
Univ Nagoya |
ヌクレオシド誘導体、ヌクレオチド誘導体及びそれらの製造方法
|
JP2006248975A
(ja)
|
2005-03-10 |
2006-09-21 |
Tokyo Institute Of Technology |
ヌクレオシドホスホロアミダイト化合物
|
WO2006105440A2
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
ES2261072B1
(es)
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
US20060240462A1
(en)
|
2005-04-21 |
2006-10-26 |
Johnson & Johnson Research Pty Limited |
Methods for amplification and detection of nucleic acids
|
US8207136B2
(en)
|
2005-04-26 |
2012-06-26 |
The Board Of Trustees Of The University Of Illinois |
Nucleoside compounds and methods of use thereof
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
JP2008542391A
(ja)
|
2005-06-01 |
2008-11-27 |
ザ スクリップス リサーチ インスティテュート |
シトクローム−リガンド複合体の結晶および使用方法
|
WO2007006544A2
(en)
|
2005-07-12 |
2007-01-18 |
Vrije Universiteit Brussel |
Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
|
JP2009505954A
(ja)
|
2005-07-21 |
2009-02-12 |
ネレアス ファーマシューティカルズ インコーポレイテッド |
インターロイキン−1及び腫瘍壊死因子−a修飾因子、このような修飾因子の合成及びこのような修飾因子の使用方法
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
CA2618335C
(en)
|
2005-08-15 |
2015-03-31 |
F.Hoffmann-La Roche Ag |
Antiviral phosphoramidates of 4'-substituted pronucleotides
|
CA2620223A1
(en)
|
2005-09-02 |
2007-03-08 |
Abbott Laboratories |
Novel imidazo based heterocycles
|
AU2006302729B2
(en)
|
2005-10-07 |
2011-02-03 |
Speedx Pty Ltd |
Multicomponent nucleic acid enzymes and methods for their use
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
JP4929288B2
(ja)
|
2005-11-04 |
2012-05-09 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
Nav1.8遺伝子の発現を抑制するための組成物および方法
|
US8318798B2
(en)
|
2005-11-24 |
2012-11-27 |
National University Corporation Hokkaldo University |
Therapeutic agent for neurodegenerative disease
|
EP1957510A1
(en)
|
2005-12-09 |
2008-08-20 |
F.Hoffmann-La Roche Ag |
Antiviral nucleosides
|
WO2007073489A2
(en)
|
2005-12-22 |
2007-06-28 |
Trustees Of Boston University |
Molecules for gene delivery and gene therapy, and methods of use thereof
|
KR20080100352A
(ko)
|
2006-01-27 |
2008-11-17 |
조지 매이슨 유니버시티 |
안구액 마커
|
EP1993611A4
(en)
|
2006-03-16 |
2013-05-22 |
Alnylam Pharmaceuticals Inc |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES
|
CA2647728C
(en)
|
2006-03-31 |
2014-12-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of eg5 gene
|
FR2900334B1
(fr)
|
2006-04-28 |
2008-06-27 |
Oreal |
Procede de depigmentation de la peau
|
EP2012799B1
(en)
|
2006-05-03 |
2016-08-24 |
Chimerix, Inc. |
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
|
WO2007149554A2
(en)
|
2006-06-22 |
2007-12-27 |
The Johns Hopkins University |
Methods for restoring neural function
|
US8470522B2
(en)
|
2006-07-20 |
2013-06-25 |
Kaohsiung Medical University |
Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same
|
AU2007300663A1
(en)
|
2006-07-21 |
2008-04-03 |
Pharmexa Inc. |
Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
|
JP2010501593A
(ja)
|
2006-08-24 |
2010-01-21 |
セレネックス, インコーポレイテッド |
イソキノリン、キナゾリンおよびフタラジン誘導体
|
WO2008027932A2
(en)
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Cytochrome p450 oxidase inhibitors and uses thereof
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
WO2008033466A2
(en)
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
GB0618235D0
(en)
|
2006-09-15 |
2006-10-25 |
Lauras As |
Process
|
RS51643B
(en)
|
2006-10-10 |
2011-10-31 |
Medivir Ab. |
INHIBITOR HCV NUKLEOZIDA
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
DK2094849T3
(en)
|
2006-11-09 |
2014-03-24 |
Dynavax Tech Corp |
LONG-TERM DISEASE MODIFICATION USING IMMUNSTIMULATORY OLIGONUCLEOTIDES
|
US7598040B2
(en)
|
2006-11-22 |
2009-10-06 |
Trana Discovery, Inc. |
Compositions and methods for the identification of inhibitors of protein synthesis
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
CA2673649A1
(en)
|
2007-01-05 |
2008-07-17 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
CA2676822A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
EP2125852B1
(en)
|
2007-02-15 |
2016-04-06 |
Ionis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
US20100015218A1
(en)
|
2007-02-16 |
2010-01-21 |
Vasant Jadhav |
Compositions and methods for potentiated activity of biologically active molecules
|
EP2144921A2
(en)
|
2007-02-27 |
2010-01-20 |
K.U. Leuven Research and Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
US20120108533A1
(en)
|
2007-02-27 |
2012-05-03 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
CN101687900A
(zh)
|
2007-03-07 |
2010-03-31 |
恩文塔生物制药公司 |
双链锁核酸组合物
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
PL211703B1
(pl)
|
2007-07-03 |
2012-06-29 |
Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk |
Tiohypofosforanowe i ditiohypofosforanowe analogi 5'-O-hypofosforanów nukleozydów i ich estry alkilowe oraz sposób ich wytwarzania
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US20100305060A1
(en)
|
2007-11-29 |
2010-12-02 |
Ligand Pharmaceuticals Incorporated |
Nucleoside Prodrugs and Uses Thereof
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
CN103816174B
(zh)
|
2008-04-03 |
2017-12-05 |
春堤制药公司 |
用于治疗病毒感染的化合物和方法
|
CA2722308C
(en)
|
2008-04-15 |
2024-02-27 |
Rfs Pharma, Llc. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
CA2946532A1
(en)
|
2008-08-15 |
2010-02-18 |
The Uab Research Foundation |
Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
|
GB0815315D0
(en)
|
2008-08-21 |
2008-09-24 |
Univ Leiden |
Organ protection
|
US8163707B2
(en)
|
2008-09-15 |
2012-04-24 |
Enanta Pharmaceuticals, Inc. |
4′-allene-substituted nucleoside derivatives
|
WO2010048549A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
|
CA2751458C
(en)
|
2009-02-06 |
2018-06-05 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
KR20110128947A
(ko)
|
2009-03-20 |
2011-11-30 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오시드 및 뉴클레오티드 유사체
|
WO2010135520A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
WO2011094489A1
(en)
|
2010-01-29 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Therapies for treating hepatitis c virus infection
|
WO2011156757A1
(en)
|
2010-06-10 |
2011-12-15 |
Gilead Sciences, Inc. |
Combination of anti-hcv compounds with ribavirin for the treatment of hcv
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
CN105061534A
(zh)
*
|
2010-09-22 |
2015-11-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
AU2011305652B2
(en)
|
2010-09-22 |
2016-10-20 |
Janssen Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
WO2012088155A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
JP2014515023A
(ja)
|
2011-04-13 |
2014-06-26 |
メルク・シャープ・アンド・ドーム・コーポレーション |
2’−置換ヌクレオシド誘導体およびウイルス疾患の処置のためのその使用方法
|
TW201313697A
(zh)
|
2011-07-26 |
2013-04-01 |
Vertex Pharma |
製備噻吩化合物之方法
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
UA117095C2
(uk)
|
2011-12-22 |
2018-06-25 |
Аліос Біофарма, Інк. |
Нуклеозидна сполука або її фармацевтично прийнятна сіль
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
EA035159B1
(ru)
|
2012-03-21 |
2020-05-06 |
Янссен Байофарма, Инк. |
Замещенные нуклеозиды, нуклеотиды и их аналоги
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
NZ630800A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Methods of preparing substituted nucleotide analogs
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
LT2935303T
(lt)
|
2012-12-21 |
2021-03-25 |
Janssen Biopharma, Inc. |
4'-fluor-nukleozidai, 4'-fluor-nukleotidai ir jų analogai, skirti hcv gydymui
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
TW201532606A
(zh)
|
2013-04-05 |
2015-09-01 |
Alios Biopharma Inc |
使用化合物之組合治療c型肝炎病毒感染
|
DK3424938T3
(da)
|
2013-06-26 |
2020-10-12 |
Janssen Biopharma Inc |
4'-azidoalkylsubstituterede nukleosider, nukleotider og analoger deraf
|
CA2913206C
(en)
|
2013-06-26 |
2022-08-02 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
KR102314960B1
(ko)
|
2013-10-11 |
2021-10-19 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 이의 유사체
|
AP2016009653A0
(en)
|
2014-06-24 |
2016-12-31 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
JP6728075B2
(ja)
|
2014-06-24 |
2020-07-22 |
ヤンセン バイオファーマ インク. |
置換ヌクレオシド、ヌクレオチドおよびその類似体
|
US20150368286A1
(en)
|
2014-06-24 |
2015-12-24 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleotide analogs
|
KR20170031231A
(ko)
|
2014-07-22 |
2017-03-20 |
앨리오스 바이오파마 인크. |
파라믹소바이러스의 치료 방법
|
WO2016022464A1
(en)
|
2014-08-05 |
2016-02-11 |
Alios Biopharma, Inc. |
Combination therapy for treating a paramyxovirus
|
US9908914B2
(en)
|
2014-10-28 |
2018-03-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|